February 13, 2019 10:53 AM EST

Charles River drops $510M to bag non-clinical CRO; Magpie raises $14.8M Series B to modernize traditional Chinese meds

→ The early-stage specialists at Charles River Laboratories are adding a team of non-clinical CRO experts to their team with a …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Charles Riv­er drops $510M to bag non-clin­i­cal CRO; Mag­pie rais­es $14.8M Se­ries B to mod­ern­ize tra­di­tion­al Chi­nese meds